| abstract |
The invention relates to a pharmaceutical composition comprising a first pharmacologically active ingredient selected from (1r, 4r) -6'-fluoro-N, N-dimethyl-4-phenyl-4 ', 9'-dihydro-3'H-spiro [cyclohexane -1,1'-pyrano [3,4, b] indole] -4-amine, which corresponds to the formula (I) and its physiologically acceptable salts, and the second pharmacologically active ingredient selected from the group consisting of acetylsalicylic acid, and physiologically acceptable salts. |